Biotech Values

[vinmantoo]

I am more disappointed by the closure of the EUA route for EDP-235 as a patient than an investor.

Ed, why would you expect an EUA to be a pathway now? I just assumed phase 3 trials would be necessary for approval as Paxlovid has regular approval.

Our good "friend" Jake once made the claim that phase 3 trials for an anti-Covid drugs wouldn't be possible. Somebody needs to tell ABBV they don't know what they are doing because they just put an anti-Covid drug in phase I testing. Most people rightly assume that ABBV wouldn't put a drug into phase I trials if they didn't have plans for it to ultimately get through phase 3 testing. I can add my $0.02 after listening to the CC later tonight.